Applied Genetic Technologies reported $47.03M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alimera Sciences ALIM:US $ -8.6M 6M
Applied Genetic Technologies AGTC:US $ 47.03M 4.46M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Biogen BIIB:US $ 11242.3M 346.1M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Cti Biopharma CTIC:US $ -27.92M 31.68M
Gilead Sciences GILD:US $ 19927M 1142M
Insmed INSM:US $ 119.88M 290.59M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
Life Technologies LIFE:US $ 98.55M 10.75M
Ophthotech OPHT:US $ 333.15M 27.37M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Rigel Pharmaceuticals RIGL:US $ 6.8M 23.58M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M